We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byAudrey Grant
Modified over 5 years ago
Endoscopic Ultrasound for Early Stage Esophageal Adenocarcinoma: Implications for Staging and Survival Traves D. Crabtree, MD, Wael N. Yacoub, MD, Varun Puri, MD, Riad Azar, MD, Jennifer Bell Zoole, BSN, G. Alexander Patterson, MD, A. Sasha Krupnick, MD, Daniel Kreisel, MD, PhD, Bryan F. Meyers, MD, MPH The Annals of Thoracic Surgery Volume 91, Issue 5, Pages (May 2011) DOI: /j.athoracsur Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Disease-free survival for clinically staged adenocarcinoma of the esophagus. (cTx designates tumors biopsied on standard endoscopy but not seen on endoscopic ultrasound (EUS) [n = 2]. T1sm is reported if noted in the EUS report.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions
Figure 2 Disease-free survival for pathologically staged adenocarcinoma of the esophagus. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions
Figure 3 Disease-free survival by pathologic upstaging/downstaging of patients with cT1-2N0 disease. (cTx designates tumors biopsied on standard endoscopy but not seen on endoscopic ultrasound (EUS). T1sm is reported if noted in the EUS report.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions
Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Evaluation of the Reliability of Clinical Staging of T2 N0 Esophageal Cancer: A Review of The Society of Thoracic Surgeons Database Traves D. Crabtree,
Does the method of radiologic surveillance affect survival after resection of stage I non– small cell lung cancer? Traves D. Crabtree, MD, Varun Puri,
Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M
Diaphragmatic Defect Complicating Peritoneal Dialysis
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD
Does the Presence of Preoperative Mild or Moderate Coronary Artery Disease Affect the Outcomes of Lung Transplantation? Cliff K. Choong, FRACS, Bryan.
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy
Endoscopic Ultrasound Estimates for Tumor Depth at the Gastroesophageal Junction Are Inaccurate: Implications for the Liberal Use of Endoscopic Resection
The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis Naoto Morimoto,
Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,
Adenocarcinoma of the Distal Esophagus in a Patient With a Magnetic Sphincter Augmentation Device: First of Many to Come? Rudolf J. Stadlhuber, MD, Attila.
National Patterns of Care and Outcomes After Combined Modality Therapy for Stage IIIA Non–Small-Cell Lung Cancer Aalok P. Patel, BS, Traves D. Crabtree,
Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D
Elizabeth H. Stephens, MD, PhD, Arlene M. Correa, PhD, Min P
Community-Based Multidisciplinary Computed Tomography Screening Program Improves Lung Cancer Survival Daniel L. Miller, MD, William R. Mayfield, MD,
Felix G. Fernandez, MD, Chadrick E. Denlinger, MD, G
Dissecting Multidisciplinary Cardiac Surgery Rounds
© 2023 SlidePlayer.com Inc. All rights reserved.